Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2026-02-01 @ 1:43 AM
Study NCT ID:
NCT03706950
Status:
UNKNOWN
Last Update Posted:
2018-10-18
First Post:
2018-10-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART
Sponsor:
Viriom
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-11
First Submit QC Date:
None
Study First Post Date:
2018-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-15
Last Update Post Date:
2018-10-18
Last Update Post Date Type:
ACTUAL